| |
| Roger
Longman |
|
Roger Longman is a Managing Partner at Windhover Information Inc.
and has been involved with the health care industry for more than
20 years, during which time he has become one of the leading experts
in pharm/bio dealmaking. He is regularly asked to speak at many
key industry events as well as at leading pharma and biotech companies.
He lectures regularly at leading universities and co-directs, with
The Wharton School, a week-long course on the pharmaceutical industry.
Mr.
Longman launched Windhover in 1989 with partner David Cassak,
creating an information provider that now leads the industry.
The company's flagship publication, IN VIVO: The Business &
Medicine Report, has been joined by Longman's creations including
Start-Up: Windhover's Review of Emerging Medical Venture; The
RPM Report: Regulatory Policy Market Access and Strategic Transactions
databases, a web-based suite of databases, which feature the most
comprehensive and detailed source of industry alliances, acquisitions
and financings. Mr. Longman was also critical in the creation
of Windhover's conference division, hosting several events annually.
|
| |
| David
Cassak |
|
David Cassak is a Managing Partner of Windhover Information and
has been involved with the health care industry for more than 20
years.
Mr. Cassak earned a BA from Drew University and did graduate work
at Columbia and Princeton, earning an MA, with honors from the former,
before joining, Cassak Publications Inc., a family-run business
that published trade journals for the hospital and alternate site
distribution industries. For much of the 1980s, he wrote and spoke
frequently about the medical/surgical and hospital supply industries,
before joining The Wilkerson Group, a health care consulting company,
in 1988, as an editor of IN VIVO: The Business & Medicine Report.
In 1989, Mr. Cassak, along with his partner Roger
Longman, led a buyout of the publications business of TheWilkerson
Group, forming Windhover Information Inc. In addition to IN VIVO,
Windhover publishes other monthly reports, including START-UP:
Windhover's Review of Emerging Medical Ventures and IN VIVO Europe
Rx: Inside Europe's Biopharma Companies. Windhover also has an
extensive database of health care transactions which has been
turned into a Web-based electronic system, Strategic Intelligence
Systems (SIS). SIS allows users to search for transactions by
a variety of criteria, including deal structure, value, and therapeutic
and scientific categories. Windhover also has a conference business
and is well-known for, among others, its Pharmaceutical Strategic
Alliances (New York), Euro-Biotech (Paris), Marketing Pharmaceutical
Alliances (Philadelphia), and Bio-Windhover (Washington) meetings.
Mr. Cassak writes extensively about the medical
device and hospital supply industries for IN VIVO and START-UP
and is a frequent speaker before various companies and industry
trade groups.
|
| |
| Stephen
Levin |
 |
Stephen Levin joined Windhover Information in 1997, specializing
in medical devices, distribution and legal issues. Prior to joining
Windhover, Steve was senior counsel to the U.S. Senate Permanent
Subcommittee on Investigations where he directed Senate investigations
into a wide variety of areas including health care fraud and abuse,
international organized crime and corruption in federal contracting
programs. Before joining the Subcommittee, Steve held various positions
in Washington including working for the Federal Election Commission
and the Department of Justice, and was an editor of Health Industry
Today. |
| |
| Sharon
L. O’Reilly |
 |
Founder of Medtech Insight, Sharon is a well known medical technology
“insider” who has over 20 years of experience advising and consulting
with the medtech industry.
Formerly the principal author and editor of “Inside Surgery”,
published by Medical
Data International, Inc., and a senior consultant on orthopedic,
surgical and biomaterials markets, Sharon brings seasoned awareness
of the implications of market developments encompassing orthopedics,
musculoskeletal, cardiovascular, interventional radiology, general
surgery and other surgical technologies.
|
|
